M. Lanzuela

Doxorubicin plus sorafenib in treatment of advanced hepatocellular carcinoma.

R. P. Pazo Cid, J. Lao, M. Lanzuela, 2011, JAMA.

Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment

G. Escames, J. Giralt, R. Mesía, 2021, Clinical and Translational Oncology.

Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)

J. Pérez-Gracia, A. Antón, P. Martín-Duque, 2012, Clinical and Translational Oncology.

Use of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study

X. Castells, M. Comas, M. Redondo, 2020, BMJ Open.

Activity of weekly paclitaxel−cetuximab chemotherapy in unselected patients with recurrent/metastatic head and neck squamous cell carcinoma: prognostic factors

A. Antón, I. Bernad, J. M. Trufero, 2017, Clinical and Translational Oncology.

Multimorbidity clusters among long‐term breast cancer survivors in Spain: Results of the SURBCAN study

X. Castells, M. Comas, I. del Cura-González, 2021, International journal of cancer.